news-med.jpg

Evotec and Celgene expand IPSC collaboration to include additional cell lines

$ 6 M payment to access additional cell lines

Topics: Corporate, Evotec, Celgene, IPSC, Induced pluripotent stem cells Read More

Evotec and CENTOGENE sign global strategic partnership on drug discovery projects in rare genetic diseases

Joint drug discovery projects combine CENTOGENE’s patient access and biomarker expertise with Evotec's leading IPSC platform  

Topics: Corporate, Evotec, Drug Discovery, CENTOGENE, rare genetic diseases, IPSC Read More

Evotec and Celgene expand IPSC collaboration to include additional cell lines

$ 6 M payment to access additional cell lines

Topics: Corporate, Celgene, IPSC, Evotec Read More

Most Read

Posts by Topic